Skip to main content
. 2020 Mar 19;93(1108):20190789. doi: 10.1259/bjr.20190789

Table 3.

Dose received by each percentage of volume at planning and treatment

Percentage of organ volume
D1% D5% D10% D35%
Organ Planning or treatment fraction number Median dose (Gy) IQR Median dose (Gy) IQR Median dose (Gy) IQR Median dose (Gy) IQR
Rectum Planning 6.76 (6.68–6.88) 6.11 (5.85–6.29) 5.22 (4.92–5.43) 2.92 (2.46–3.37)
1 7.00 (6.85–7.12) 6.52 (6.18–6.76) 5.63 (5.23–6.12) 3.20 (2.85–3.47)
2 6.96 (6.81–7.07) 6.50 (5.90–6.78) 5.66 (4.96–6.20) 3.29 (2.72–3.56)
3 6.98 (6.71–7.07) 6.44 (5.82–6.67) 5.61 (5.05–6.00) 3.17 (2.84–3.55)
4 6.98 (6.77–7.08) 6.31 (5.98–6.68) 5.45 (4.91–5.97) 3.22 (2.76–3.40)
5 6.98 (6.75–7.14) 6.40 (6.06–6.76) 5.63 (5.21–6.15) 3.32 (2.83–3.74)
Bladder Planning 6.83 (6.68–6.89) 5.76 (5.16–6.64) 4.42 (3.72–5.76) 1.08 (0.59–2.38)
1 7.05 (6.83–7.16) 6.45 (5.58–6.88) 4.97 (3.94–6.27) 1.65 (0.60–2.63)
2 7.03 (6.73–7.15) 6.15 (5.10–6.78) 4.21 (3.54–5.64) 1.47 (0.50–2.35)
3 6.97 (6.72–7.11) 5.95 (4.80–6.85) 4.20 (3.58–5.91) 1.00 (0.71–2.25)
4 6.84 (6.70–7.12) 5.82 (5.13–6.88) 4.31 (3.52–6.24) 1.22 (0.60–2.53)
5 6.99 (6.78–7.15) 6.26 (5.49–6.81) 4.54 (3.70–5.85) 1.60 (0.62–2.52)

IQR, interquartile range.